EMEA approval News
Most Popular EMEA approval Story
Bristol exec hints of Onglyza launch strategy
Now that AstraZeneca and Bristol-Myers Squibb have the EMEA's nod on Onglyza, they're revving up to launch the new diabetes remedy. First target: Germany. Timing: By the end of this quarter. Now, the... Read more...
Latest Headlines
- July 9, 2009
- July 6, 2009
- July 1, 2009
- June 19, 2009
- May 15, 2009
- April 20, 2009
- February 13, 2009
- November 13, 2008
- October 24, 2008
- October 3, 2008
- May 14, 2008
- March 27, 2008
- January 28, 2008
- August 30, 2007
- August 24, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
